156 related articles for article (PubMed ID: 24393950)
1. [Pancreatic cancer showing complete pathological response to preoperative chemoradiotherapy-a case report].
Tanizaki K; Hama N; Tomimaru Y; Eguchi H; Akita H; Wada H; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1872-4. PubMed ID: 24393950
[TBL] [Abstract][Full Text] [Related]
2. [A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy].
Hasegawa K; Katsuta E; Iwata N; Aoyagi H; Yoshida T; Takahata T; Kaneko J; Maejima S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2152-4. PubMed ID: 22202313
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01).
Hayashi T; Nakamura T; Kimura Y; Yoshida M; Someya M; Kawakami H; Sakuhara Y; Katoh N; Takahashi K; Ambo Y; Miura K; Motoya M; Tanaka E; Murakawa K; Yamabuki T; Yamazaki H; Katanuma A; Hirano S;
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):606-617. PubMed ID: 31306735
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement.
Nagakawa Y; Hosokawa Y; Nakayama H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasuya K; Katsumata K; Tokuuye K; Tsuchida A
Cancer Chemother Pharmacol; 2017 May; 79(5):951-957. PubMed ID: 28378027
[TBL] [Abstract][Full Text] [Related]
5. [A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy].
Murata A; Kimura K; Amano R; Hirata K; Nagahara H; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Otani H; Maeda K; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1865-7. PubMed ID: 24393948
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.
Tomihara H; Eguchi H; Yamada D; Gotoh K; Kawamoto K; Wada H; Asaoka T; Noda T; Takeda Y; Tanemura M; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):218-226. PubMed ID: 27586014
[TBL] [Abstract][Full Text] [Related]
7. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
[TBL] [Abstract][Full Text] [Related]
8. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.
Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F
World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537
[TBL] [Abstract][Full Text] [Related]
9. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.
Amano R; Kimura K; Nakata B; Yamazoe S; Motomura H; Yamamoto A; Tanaka S; Hirakawa K
Surgery; 2015 Jul; 158(1):191-200. PubMed ID: 25900035
[TBL] [Abstract][Full Text] [Related]
10. [A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer].
Watanabe F; Honda G; Kurata M; Tsuruta K; Tokashiki T; Funada N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2430-2. PubMed ID: 20037446
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Radical Resection for Locally Advanced Pancreatic Cancer with Positive Peritoneal Cytology Treated with Chemoradiotherapy].
Sato R; Takizawa K; Yuza K; Soma D; Hirose Y; Morimoto Y; Miura K; Nagahashi M; Takano K; Sakata J; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Wakai T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2385-7. PubMed ID: 26805372
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer.
Sudo K; Hara R; Nakamura K; Kita E; Tsujimoto A; Yamaguchi T
Cancer Chemother Pharmacol; 2017 Jul; 80(1):195-202. PubMed ID: 28597040
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer.
Nakachi K; Furuse J; Kinoshita T; Kawashima M; Ishii H; Ikeda M; Mitsunaga S; Shimizu S
Cancer Chemother Pharmacol; 2010 Aug; 66(3):527-34. PubMed ID: 19967537
[TBL] [Abstract][Full Text] [Related]
14. [A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy].
Kitasato Y; Yasunaga M; Nakayama M; Akasu G; Yoshitomi M; Mikagi K; Kawahara R; Ishikawa H; Hisaka T; Horiuchi H; Kinoshita H; Okabe Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2161-4. PubMed ID: 22202316
[TBL] [Abstract][Full Text] [Related]
15. [Regrowth of Isolated Local Residual Tumor Effectively Treated with Chemoradiotherapy More Than Five Years after a Resection for Pancreatic Cancer with an Involvement of the Portal Vein].
Matsumura T; Totsuka E; Kitamura K; Okada K; Inose S; Koyama M; Nakamura N; Masamura S; Karikomi K; Suwa T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2344-2346. PubMed ID: 28133316
[TBL] [Abstract][Full Text] [Related]
16. [The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy].
Imamura T; Ikoma H; Morimura R; Hatakeyama T; Kosuga T; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2379-81. PubMed ID: 26805370
[TBL] [Abstract][Full Text] [Related]
17. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
[TBL] [Abstract][Full Text] [Related]
19. Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma.
Homma Y; Taniguchi K; Murakami T; Nakagawa K; Nakazawa M; Matsuyama R; Mori R; Takeda K; Ueda M; Ichikawa Y; Tanaka K; Endo I
Ann Surg Oncol; 2014 Feb; 21(2):670-6. PubMed ID: 24310792
[TBL] [Abstract][Full Text] [Related]
20. A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.
Kobayashi S; Honda G; Kurata M; Okuda Y; Sakamoto K; Karasawa K; Chang T; Egawa N; Kamisawa T; Omuro Y; Tsuruta K
Hepatogastroenterology; 2015 Jun; 62(140):1031-6. PubMed ID: 26902051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
